Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keros Therapeutics (KROS)
NASDAQ:KROS
Keros Therapeutics (KROS) Ownership - Who Owns Keros Therapeutics?
207 Followers
Keros Therapeutics (KROS) Ownership Overview
30.18% Insiders
23.85% Mutual Funds
12.50% Other Institutional Investors
33.47% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail and individual investors. Approximately 36.35% of the company’s stock is owned by Institutional Investors, 30.18% is owned by Insiders and 33.47% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $2298133 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $50424540 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,629,594 | Institution | 4.52% | 78,839,758 | |
| 1,408,933 | Institution | 3.90% | 68,164,179 | |
| 1,197,007 | Institution | 3.32% | 57,911,199 | |
| 1,067,083 | Institution | 2.96% | 51,625,476 | |
| 1,055,129 | Institution | 2.92% | 51,047,141 | |
| 926,383 | Institution | 2.57% | 44,818,410 | |
| 809,600 | Institution | 2.24% | 39,168,448 | |
| 761,700 | Institution | 2.11% | 36,851,046 | |
| 680,000 | Institution | 1.88% | 32,898,400 | |
| 630,644 | Institution | 1.75% | 30,510,557 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,197,007 | Institution | 3.32% | 57,911,199 | |
| 1,067,083 | Institution | 2.96% | 51,625,476 | |
| 1,055,129 | Institution | 2.92% | 51,047,141 | |
| 926,383 | Institution | 2.57% | 44,818,410 | |
| 809,600 | Institution | 2.24% | 39,168,448 | |
| 680,000 | Institution | 1.88% | 32,898,400 | |
| 486,126 | Institution | 1.35% | 23,518,776 | |
| 423,700 | Institution | 1.17% | 20,498,606 | |
| 272,273 | Institution | 0.75% | 13,172,568 | |
| 268,640 | Institution | 0.74% | 12,996,803 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 959,822 | Institution | 2.66% | 43,863,865 | |
| 780,785 | Institution | 2.16% | 37,774,378 | |
| 591,462 | Institution | 1.64% | 28,402,005 | |
| 422,774 | Institution | 1.17% | 19,320,772 | |
| 263,745 | Institution | 0.73% | 12,759,983 | |
| 197,802 | Institution | 0.55% | 9,569,661 | |
| 131,541 | Institution | 0.36% | 6,316,599 | |
| 109,653 | Institution | 0.30% | 5,265,537 | |
| 109,653 | Institution | 0.30% | 5,265,537 | |
| 109,696 | Institution | 0.30% | 5,013,107 |
FAQ
Who Owns Keros Therapeutics (KROS)?
According to the latest TipRanks data, approximately 12.50% of the company's stock is held by institutional investors, 30.18% is held by insiders, and 33.47% is held by retail investors.
What percentage of Keros Therapeutics (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.50% of Keros Therapeutics (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.47% of Keros Therapeutics (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics (KROS)?
Vanguard owns the most shares of Keros Therapeutics (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.